Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (AI116240-01A1)
Received: 20 June 2018
Accepted: 9 January 2019
First Online: 16 January 2019
Ethics approval and consent to participate
: The study was reviewed and approved by the Texas Tech University Health Sciences Center’s regional Institutional Review Board (IRB). All methods were performed in accordance with the relevant guidelines and regulations. The study design was cross-sectional and the study number recorded as IRB# E12092, approval date 07/31/2012. All participants were provided with written and oral information about the study. Written informed consent of all study participants in accordance with the Institutional policy was documented. All participants were identified by coded numbers to assure anonymity and all patient records kept confidential.
: Not applicable.
: The authors declare that they have no competing financial and/or non-financial interests in relation to the work described.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.